Skip to Main Content

WASHINGTON — Janet Woodcock, one of the FDA’s most powerful regulators, has an almost mythic reputation and an outsized personality to match. For years, rumors have swirled: Who could possibly succeed her?

Now, it seems, there’s an answer to that question: The FDA official who has been tapped to step into Woodcock’s role for at least a temporary stint is a relative newcomer — and until now, a relatively quiet, low-profile presence at an agency that has been thrust into the spotlight amid the coronavirus pandemic.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED